Cargando…

Secondary Structure Changes in ApoA-I Milano (R173C) Are Not Accompanied by a Decrease in Protein Stability or Solubility

Apolipoprotein A-I (apoA-I) is the main protein of high-density lipoprotein (HDL) and a principal mediator of the reverse cholesterol transfer pathway. Variants of apoA-I have been shown to be associated with hereditary amyloidosis. We previously characterized the G26R and L178H variants that both p...

Descripción completa

Detalles Bibliográficos
Autores principales: Petrlova, Jitka, Dalla-Riva, Jonathan, Mörgelin, Matthias, Lindahl, Maria, Krupinska, Ewa, Stenkula, Karin G., Voss, John C., Lagerstedt, Jens O.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3995965/
https://www.ncbi.nlm.nih.gov/pubmed/24755625
http://dx.doi.org/10.1371/journal.pone.0096150
_version_ 1782312962724200448
author Petrlova, Jitka
Dalla-Riva, Jonathan
Mörgelin, Matthias
Lindahl, Maria
Krupinska, Ewa
Stenkula, Karin G.
Voss, John C.
Lagerstedt, Jens O.
author_facet Petrlova, Jitka
Dalla-Riva, Jonathan
Mörgelin, Matthias
Lindahl, Maria
Krupinska, Ewa
Stenkula, Karin G.
Voss, John C.
Lagerstedt, Jens O.
author_sort Petrlova, Jitka
collection PubMed
description Apolipoprotein A-I (apoA-I) is the main protein of high-density lipoprotein (HDL) and a principal mediator of the reverse cholesterol transfer pathway. Variants of apoA-I have been shown to be associated with hereditary amyloidosis. We previously characterized the G26R and L178H variants that both possess decreased stability and increased fibril formation propensity. Here we investigate the Milano variant of apoAI (R173C; apoAI-M), which despite association with low plasma levels of HDL leads to low prevalence of cardiovascular disease in carriers of this mutation. The R173C substitution is located to a region (residues 170 to 178) that contains several fibrillogenic apoA-I variants, including the L178H variant, and therefore we investigated a potential fibrillogenic property of the apoAI-M protein. Despite the fact that apoAI-M shared several features with the L178H variant regarding increased helical content and low degree of ThT binding during prolonged incubation in physiological buffer, our electron microscopy analysis revealed no formation of fibrils. These results suggest that mutations inducing secondary structural changes may be beneficial in cases where fibril formation does not occur.
format Online
Article
Text
id pubmed-3995965
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-39959652014-04-25 Secondary Structure Changes in ApoA-I Milano (R173C) Are Not Accompanied by a Decrease in Protein Stability or Solubility Petrlova, Jitka Dalla-Riva, Jonathan Mörgelin, Matthias Lindahl, Maria Krupinska, Ewa Stenkula, Karin G. Voss, John C. Lagerstedt, Jens O. PLoS One Research Article Apolipoprotein A-I (apoA-I) is the main protein of high-density lipoprotein (HDL) and a principal mediator of the reverse cholesterol transfer pathway. Variants of apoA-I have been shown to be associated with hereditary amyloidosis. We previously characterized the G26R and L178H variants that both possess decreased stability and increased fibril formation propensity. Here we investigate the Milano variant of apoAI (R173C; apoAI-M), which despite association with low plasma levels of HDL leads to low prevalence of cardiovascular disease in carriers of this mutation. The R173C substitution is located to a region (residues 170 to 178) that contains several fibrillogenic apoA-I variants, including the L178H variant, and therefore we investigated a potential fibrillogenic property of the apoAI-M protein. Despite the fact that apoAI-M shared several features with the L178H variant regarding increased helical content and low degree of ThT binding during prolonged incubation in physiological buffer, our electron microscopy analysis revealed no formation of fibrils. These results suggest that mutations inducing secondary structural changes may be beneficial in cases where fibril formation does not occur. Public Library of Science 2014-04-22 /pmc/articles/PMC3995965/ /pubmed/24755625 http://dx.doi.org/10.1371/journal.pone.0096150 Text en © 2014 Petrlova et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Petrlova, Jitka
Dalla-Riva, Jonathan
Mörgelin, Matthias
Lindahl, Maria
Krupinska, Ewa
Stenkula, Karin G.
Voss, John C.
Lagerstedt, Jens O.
Secondary Structure Changes in ApoA-I Milano (R173C) Are Not Accompanied by a Decrease in Protein Stability or Solubility
title Secondary Structure Changes in ApoA-I Milano (R173C) Are Not Accompanied by a Decrease in Protein Stability or Solubility
title_full Secondary Structure Changes in ApoA-I Milano (R173C) Are Not Accompanied by a Decrease in Protein Stability or Solubility
title_fullStr Secondary Structure Changes in ApoA-I Milano (R173C) Are Not Accompanied by a Decrease in Protein Stability or Solubility
title_full_unstemmed Secondary Structure Changes in ApoA-I Milano (R173C) Are Not Accompanied by a Decrease in Protein Stability or Solubility
title_short Secondary Structure Changes in ApoA-I Milano (R173C) Are Not Accompanied by a Decrease in Protein Stability or Solubility
title_sort secondary structure changes in apoa-i milano (r173c) are not accompanied by a decrease in protein stability or solubility
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3995965/
https://www.ncbi.nlm.nih.gov/pubmed/24755625
http://dx.doi.org/10.1371/journal.pone.0096150
work_keys_str_mv AT petrlovajitka secondarystructurechangesinapoaimilanor173carenotaccompaniedbyadecreaseinproteinstabilityorsolubility
AT dallarivajonathan secondarystructurechangesinapoaimilanor173carenotaccompaniedbyadecreaseinproteinstabilityorsolubility
AT morgelinmatthias secondarystructurechangesinapoaimilanor173carenotaccompaniedbyadecreaseinproteinstabilityorsolubility
AT lindahlmaria secondarystructurechangesinapoaimilanor173carenotaccompaniedbyadecreaseinproteinstabilityorsolubility
AT krupinskaewa secondarystructurechangesinapoaimilanor173carenotaccompaniedbyadecreaseinproteinstabilityorsolubility
AT stenkulakaring secondarystructurechangesinapoaimilanor173carenotaccompaniedbyadecreaseinproteinstabilityorsolubility
AT vossjohnc secondarystructurechangesinapoaimilanor173carenotaccompaniedbyadecreaseinproteinstabilityorsolubility
AT lagerstedtjenso secondarystructurechangesinapoaimilanor173carenotaccompaniedbyadecreaseinproteinstabilityorsolubility